1 – 10 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer
- 2012
- Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
- Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
- Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
- Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
- Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
- 2010
- The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
- KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis
- 2009
- Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee